ACH Accendra Health, Inc. Common Stock
NYSE · Health Care · SEC EDGAR에서 보기 ↗ 종가 10월 2, 2026 10-K/10-Q 1월 24, 2024ACH 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
ACH 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
막대 세분성은 선택한 기간에 따라 조정됩니다. 막대의 시가/고가/저가/종가를 보려면 차트에 마우스를 올리세요.
| 배당락일 | 분할 | 유형 |
|---|---|---|
| 2010년 4월 1일 | 3-for-2 | 정방향 |
| 1994년 6월 9일 | 3-for-2 | 정방향 |
| 1993년 3월 23일 | 3-for-2 | 정방향 |
| 1991년 7월 17일 | 3-for-2 | 정방향 |
| 1988년 6월 1일 | 3-for-2 | 정방향 |
| 1985년 9월 3일 | 3-for-2 | 정방향 |
| 1982년 11월 1일 | 2-for-1 | 정방향 |
Accendra Health, Inc. Common Stock 정보 위키백과 회사 개요
Accendra Health is a global healthcare company. It employs over 20,000 people in 70 countries. A Fortune 500 company, it was founded in 1882 in Richmond, Virginia, where it remains headquartered. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. President and CEO Ed Pesicka joined Owens & Minor in March 2019.
History
Owens & Minor originally opened as a pharmacy company in downtown Richmond, Virginia in 1882, inside a historic building which still stands today. The company continued this business for over half a century until, in 1954, Gil Minor, Jr. bought out Bodeker Drug Company, a smaller operation in the same industry, changing the company name to Owens, Minor & Bodeker.
In 1966, the company acquired Virginia A&J Hospital Supply, adding medical and surgical distribution to its portfolio. By 1970, OMB had opened Cardinal Drug Centers, merchandising its products to independent drug companies, stocking shops with over 25,000 items within two years. Around this time, disposable items were distributed to hospitals for various medical procedures. G. Gilmer Minor III, a direct relation to the founder, became CEO in 1984. By 1988, Owens & Minor began trading on the New York Stock Exchange under the ticker OMI. It was around this time that revenues earned the company a Fortune 500 ranking.
By 1999, the company had refocused toward medical supply chain management. Throughout the 2000s, Owens & Minor acquired various medical distributors across the United States, notably the hospital distributor McKesson Medical-Surgical Inc., a business unit of McKesson, for $152.1 million, on September 30, 2006. In 2012, it entered the European market, opening offices in Spain, France, Germany, Poland, and the Czech Republic after the acquisition of Movianto Group. In 2014, the corporation acquired ArcRoyal, a privately held medical kit company based in Dublin, Ireland.
In 2018, it acquired Halyard Health’s Surgical & Infection Prevention business for $710 million, the largest acquisition in the company’s history. Halyard is a manufacturer of sterilization wrap, facial protection products, exam gloves, protective apparel, surgical drapes and surgical gowns.
In May 2022, Owens & Minor stated that 45 percent of the items it offers are in some way supply-constrained due to the 2021–2022 global supply chain crisis. The following month, the company broke ground in Morgantown, West Virginia for a 350,000 square-foot medical supplies and logistics center, to be completed in late 2023, which will include dedicated acute care medical distribution facilities and clinical supply capabilities.
In July 2024, the company announced it had agreed to acquire medical equipment firm Rotech Healthcare for $1.36 billion. However, the companies terminated the deal in June 2025, citing regulatory hurtles. As a result, the Owens & Minor paid Rotech an $80 million termination payment.
Personnel
On March 7, 2019 Edward A. Pesicka became president and CEO, then also joined the company's Board of Directors. Pesicka was a former executive at Thermo Fisher Scientific.
Richmond, Virginia center
In the fourth quarter of 2017, Owens & Minor opened a second office and customer service center in downtown Richmond, Virginia as part of a business rebranding strategy. The corporation also continued to work from its various offices across the United States.
Movianto
In 2018, the company’s Movianto subsidiary won a contract estimated at £10.5m a year to warehouse and distribute the UK government’s stock of emergency personal protection equipment (PPE) which had previously been managed by DHL.
Following a dispute over payment of rent, Movianto gained a UK High Court injunction in March 2019 to stop Industrial North West LLP, owner of the rented industrial property, from locking the gates and thereby preventing the company from conducting its business.
In 2020, Movianto was criticised as causing delays to the distribution of the UK government’s stockpile of PPE. Following news of shortages in hospitals, the British army was sent to Movianto’s warehouse to assist in the rapid deployment of PPE, with the Department of Health and Social Care contradicting the allegation. An investigation did establish, however, that Movianto had previously stored the equipment in a smoke-damaged warehouse that was found to contain asbestos.
On January 16, 2020, Owens & Minor announced its intention to sell its European logistics business, Movianto, to EHDH Holding Group (EHDH), a privately held French company providing healthcare logistics services to European markets, with the sale completed June 18, 2020.
Divest of P&HS - Rebrand Accendra Health, Inc.
On December 31 2025, Owens & Minor, Inc. announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc.
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
이 비율 그룹을 계산하기에 기본 데이터가 아직 충분하지 않습니다.
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
이 비율 그룹을 계산하기에 기본 데이터가 아직 충분하지 않습니다.
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
이 비율 그룹을 계산하기에 기본 데이터가 아직 충분하지 않습니다.
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
이 비율 그룹을 계산하기에 기본 데이터가 아직 충분하지 않습니다.
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
이 비율 그룹을 계산하기에 기본 데이터가 아직 충분하지 않습니다.
가치 · ≈ 5년 평균 · 산업 중앙값 · 중앙값 대비 평가
배당금 배당 수익률, 지급 비율, 배당 이력, 5년 CAGR
| 배당락일 | 금액 | 통화 | 수익률 |
|---|---|---|---|
| 12월 14, 2021 | $0.00 | USD | ≈0.03% |
| 9월 14, 2021 | $0.00 | USD | ≈0.03% |
| 6월 14, 2021 | $0.00 | USD | ≈0.03% |
| 3월 12, 2021 | $0.00 | USD | ≈0.03% |
| 12월 14, 2020 | $0.00 | USD | ≈0.04% |
| 9월 14, 2020 | $0.00 | USD | ≈0.08% |
| 6월 12, 2020 | $0.00 | USD | ≈0.16% |
| 3월 13, 2020 | $0.00 | USD | ≈0.28% |
| 12월 13, 2019 | $0.00 | USD | ≈1.6% |
| 9월 13, 2019 | $0.00 | USD | ≈5.5% |
| 6월 13, 2019 | $0.00 | USD | ≈20.8% |
| 3월 14, 2019 | $0.00 | USD | ≈12.6% |
| 12월 14, 2018 | $0.08 | USD | ≈13.2% |
| 9월 14, 2018 | $0.26 | USD | ≈6.4% |
| 6월 14, 2018 | $0.26 | USD | ≈6.4% |
| 3월 14, 2018 | $0.26 | USD | ≈6.2% |
| 12월 14, 2017 | $0.26 | USD | ≈5.5% |
| 9월 14, 2017 | $0.26 | USD | ≈3.6% |
| 6월 13, 2017 | $0.26 | USD | ≈3.2% |
| 3월 13, 2017 | $0.26 | USD | ≈2.9% |
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | 보고서 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|---|
| 2026년 6월 30일 | 8월 10, 2026 | $-0.19 | $-0.09 | -113.0% |
| 2026년 3월 31일 | $-0.04 | $-0.10 | 60.9% | |
| 2025년 12월 31일 | $0.21 | $0.22 | -5.8% | |
| 2025년 9월 30일 | $0.25 | $0.23 | 6.7% | |
| 2025년 6월 30일 | $0.26 | $0.28 | -6.3% | |
| 2025년 3월 31일 | $0.23 | $0.20 | 16.6% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서
| 지표 | 추세 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $290.99B | $298.89B | $203.99B | $190.22B | $180.35B | $181.02B | $144.85B | |
| Cost of Revenue | $259.70B | $264.17B | $188.52B | $179.28B | $167.11B | $166.29B | $133.70B | |
| Gross Profit | $31.28B | $34.72B | $15.47B | $10.93B | $13.24B | $14.73B | $11.15B | |
| R&D Expense | $4.81B | $2.42B | $1.47B | $941M | $627M | $498M | $169M | |
| SG&A Expense | $6.01B | $6.33B | $5.06B | $3.97B | $3.98B | $4.55B | · | |
| Operating Income | $16.39B | $18.67B | $7.60B | $6.21B | $6.82B | · | · | |
| Interest Expense | $3.83B | $4.51B | $4.99B | $4.38B | $4.69B | $4.83B | $4.76B | |
| Interest Income | $477M | $311M | $266M | $261M | $492M | $707M | $816M | |
| Pretax Income | $13.21B | $14.19B | $2.89B | $1.87B | $2.27B | $3.05B | $1.62B | |
| Income Tax | $2.37B | $2.87B | $641M | $632M | $826M | $644M | $404M | |
| Net Income | $4.19B | $5.76B | $862M | $596M | $709M | $1.41B | $366M | |
| EPS (Basic) | $0.24 | $0.33 | $0.03 | $0.02 | $0.03 | $0.09 | $0.02 | |
| EPS (Diluted) | $0.24 | $0.33 | $0.03 | $0.02 | · | · | · | |
| Shares (Basic) | 17,022,673 | 17,022,673 | 17,022,673 | 17,022,673 | 16,842,714 | 14,903,798,236 | 14,903,798,236 | |
| Shares (Diluted) | · | · | · | 17,022,672,951 | 16,842,713,738 | 14,903,798,236 | 14,903,798,236 | |
| EBITDA | $16.39B | $13.41B | $6.02B | · | · | · | · |
대차대조표
| 지표 | 추세 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16.82B | $19.68B | $9.67B | $7.78B | $19.13B | $27.85B | $23.85B | |
| Receivables | $5.87B | $7.11B | $9.31B | $7.42B | $8.10B | · | · | |
| Inventory | $24.71B | $21.64B | $19.86B | $19.52B | $20.46B | $20.55B | $17.93B | |
| Current Assets | $54.54B | $54.11B | $46.27B | $48.70B | $58.90B | $68.64B | $66.49B | |
| PP&E (Net) | $109.28B | $121.38B | $130.93B | $103.49B | $99.61B | $95.73B | $90.37B | |
| Goodwill | $3.50B | $3.51B | $3.51B | · | · | · | · | |
| Total Assets | $212.35B | $224.86B | $195.04B | $203.14B | $200.96B | $199.82B | $190.51B | |
| Current Liabilities | $62.37B | $61.92B | $62.63B | $69.20B | $74.84B | $90.34B | $83.18B | |
| Total Liabilities | $124.59B | $135.17B | $123.74B | $132.38B | $133.30B | $134.07B | $134.72B | |
| Retained Earnings | $10.09B | $6.81B | $-1.98B | $-2.21B | $-2.86B | $-3.33B | $-4.64B | |
| Stockholders' Equity | $54.40B | $60.48B | $54.45B | $54.67B | $52.42B | $39.69B | $38.17B |
현금 흐름
| 지표 | 추세 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $8.06B | $7.06B | $7.00B | |
| Operating Cash Flow | $27.75B | $35.16B | $19.42B | $12.51B | $13.02B | $13.21B | $11.61B | |
| CapEx | $4.42B | $3.19B | $10.33B | $9.05B | $6.75B | $8.89B | $6.33B | |
| Investing Cash Flow | $-3.42B | $-1.67B | $-3.31B | $-13.40B | $-5.53B | $-5.60B | $-2.63B | |
| Dividends Paid | $2.51B | $579M | $423M | $223M | $328M | $309M | $20M | |
| Financing Cash Flow | $-27.04B | $-23.41B | $-18.23B | $-10.47B | $-16.28B | $-3.39B | $-6.11B | |
| Free Cash Flow | $23.33B | $26.19B | $9.84B | $3.58B | · | · | · | |
| Levered FCF | $20.19B | $23.50B | $7.02B | $501M | · | · | · |
수익성
| 지표 | 추세 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 10.8% | 9.8% | 7.2% | 6.4% | · | · | · | |
| Operating Margin | 5.6% | 5.0% | 3.2% | · | · | · | · | |
| Net Margin | 1.4% | 1.9% | 0.40% | 0.45% | · | · | · | |
| Pretax Margin | 4.5% | 3.8% | 1.2% | 1.1% | · | · | · | |
| EBITDA Margin | 5.6% | 5.0% | 3.2% | · | · | · | · | |
| ROA | 1.9% | 2.6% | 0.37% | 0.42% | · | · | · | |
| ROE | 7.3% | 9.1% | 1.4% | 1.6% | · | · | · | |
| ROIC | 24.7% | 17.9% | 8.1% | · | · | · | · |
유동성 및 지급능력
| 지표 | 추세 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.7 | 0.7 | · | · | · | |
| Quick Ratio | 0.4 | 0.5 | 0.3 | 0.2 | · | · | · | |
| Interest Coverage | 4.3 | 3.8 | 1.6 | · | · | · | · |
효율성
| 지표 | 추세 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.4 | 0.9 | 0.9 | · | · | · | |
| Inventory Turnover | 11.2 | 12.6 | 8.8 | 8.9 | · | · | · | |
| Receivables Turnover | 44.8 | 33.3 | 22.3 | 24.5 | · | · | · |
주당
| 지표 | 추세 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | · | · | · | $11.17 | · | · | · | |
| Cash Flow / Share | · | · | · | $0.73 | · | · | · | |
| EPS (TTM) | $0.24 | $0.29 | $0.03 | $0.02 | · | · | · |
가치 평가 (TTM)
| 지표 | 추세 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $290.99B | $269.75B | $185.99B | $190.22B | · | · | · | |
| Net Income TTM | $4.19B | $5.08B | $764M | $596M | · | · | · | |
| P/E | 81.7 | 152.1 | 901.7 | 235.0 | · | · | · | |
| Earnings Yield | 1.2% | 0.66% | 0.11% | 0.43% | · | · | · | |
| Payout Ratio | 60.0% | 9.1% | 48.1% | 26.2% | · | · | · | |
| Annual Payout | $2.51B | $461M | $356M | $223M | · | · | · |
주당
| 지표 | 추세 | Q4 2022 | Q4 2021 | Q4 2019 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | · | $0.29 | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM)
| 지표 | 추세 | Q4 2022 | Q4 2021 | Q4 2019 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $269.75B | · | · | $144.85B | $123.67B | · | · | · | · | · | |
| Net Income TTM | · | $5.08B | · | · | $366M | $130M | · | · | · | · | · | |
| P/E | · | 152.1 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | 0.66% | · | · | · | · | · | · | · | · | · | |
| Annual Payout | · | $461M | · | · | $20M | $20M | · | · | · | · | · |
최신 기간은 왼쪽에 · null 값은 ·로 표시
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
| 지표 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| 매출 | $290.99B | $298.89B | $203.99B | $190.22B | $180.35B |
| 매출 총이익률 % | 10.8% | 9.8% | 7.2% | 6.4% | · |
| 영업이익률 % | 5.6% | 5.0% | 3.2% | · | · |
| 순이익 | $4.19B | $5.76B | $862M | $596M | $709M |
| 희석 EPS | $0.24 | $0.33 | $0.03 | $0.02 | · |
| 지표 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| 유동비율 | 0.9 | 0.9 | 0.7 | 0.7 | · |
| 당좌 비율 | 0.4 | 0.5 | 0.3 | 0.2 | · |
| 지표 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| 잉여현금흐름 | $23.33B | $26.19B | $9.84B | $3.58B | · |
기관 투자자 (13F) 161개의 제출자 · $236.6M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 22 (-7 이전 분기 대비) | 21 (-25 이전 분기 대비) | 47 (+8 이전 분기 대비) | 45 (-7 이전 분기 대비) | -61K |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| Coliseum Capital Management, LLC | $44,804,760 | 13,100,807 | 18.94% | 주식 |
| BlackRock, Inc. | $18,824,028 | 5,504,102 | 7.96% | 주식 |
| VANGUARD GROUP INC | $17,691,199 | 6,318,285 | 7.48% | 주식 |
| BANK OF AMERICA CORP /DE/ | $12,912,296 | 3,775,525 | 5.46% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $10,560,724 | 3,087,931 | 4.46% | 주식 |
| D. E. Shaw & Co., Inc. | $10,538,412 | 3,081,407 | 4.45% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9,877,158 | 2,888,058 | 4.17% | 주식 |
| Invenomic Capital Management LP | $9,618,661 | 2,812,474 | 4.07% | 주식 |
| MARSHALL WACE, LLP | $8,832,423 | 2,582,579 | 3.73% | 주식 |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $8,675,511 | 2,536,699 | 3.67% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6,945,870 | 2,030,956 | 2.94% | 주식 |
| Dana Investment Advisors, Inc. | $6,650,556 | 1,944,607 | 2.81% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $6,408,062 | 1,873,127 | 2.71% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $5,609,358 | 1,640,163 | 2.37% | 주식 |
| STATE STREET CORP | $5,475,974 | 1,601,162 | 2.31% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $4,407,652 | 1,288,787 | 1.86% | 주식 |
| AQR CAPITAL MANAGEMENT LLC | $3,650,249 | 1,067,324 | 1.54% | 주식 |
| GOLDMAN SACHS GROUP INC | $2,923,176 | 854,730 | 1.24% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $2,457,441 | 718,550 | 1.04% | 주식 |
| NORTHERN TRUST CORP | $1,989,770 | 581,804 | 0.84% | 주식 |
| WOLVERINE ASSET MANAGEMENT LLC | $1,942,847 | 568,084 | 0.82% | 주식 |
| TUDOR INVESTMENT CORP ET AL | $1,939,995 | 567,250 | 0.82% | 주식 |
| JANE STREET GROUP, LLC | $1,833,462 | 536,100 | 0.77% | 콜 옵션 |
| Vanguard Global Advisers, LLC | $1,742,463 | 509,492 | 0.74% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $1,665,913 | 487,109 | 0.70% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,575,252 | 460,600 | 0.67% | 콜 옵션 |
| TWO SIGMA ADVISERS, LP | $1,518,922 | 542,472 | 0.64% | 주식 |
| BW Gestao de Investimentos Ltda. | $1,446,971 | 423,091 | 0.61% | 주식 |
| CITADEL ADVISORS LLC | $1,321,919 | 386,526 | 0.56% | 주식 |
| CITADEL ADVISORS LLC | $1,191,528 | 348,400 | 0.50% | 콜 옵션 |
| Nebula Research & Development LLC | $1,115,105 | 122,539 | 0.47% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $1,109,492 | 324,413 | 0.47% | 주식 |
| MORGAN STANLEY | $1,052,342 | 307,701 | 0.44% | 주식 |
| Linden Thomas Advisory Services, LLC | $932,501 | 272,661 | 0.39% | 주식 |
| Bank of New York Mellon Corp | $917,257 | 268,204 | 0.39% | 주식 |
| Nuveen, LLC | $803,515 | 234,946 | 0.34% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $794,692 | 232,366 | 0.34% | 주식 |
| Kennondale Capital Management LLC | $772,544 | 225,890 | 0.33% | 주식 |
| STRS OHIO | $716,148 | 209,400 | 0.30% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $690,902 | 202,018 | 0.29% | 주식 |
| Cubist Systematic Strategies, LLC | $593,424 | 123,630 | 0.25% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $546,095 | 159,677 | 0.23% | 주식 |
| WELLS FARGO & COMPANY/MN | $542,754 | 158,700 | 0.23% | 주식 |
| XTX Topco Ltd | $503,725 | 147,288 | 0.21% | 주식 |
| ARISTEIA CAPITAL, L.L.C. | $447,391 | 130,816 | 0.19% | 주식 |
| Invesco Ltd. | $446,351 | 130,512 | 0.19% | 주식 |
| Man Group plc | $436,009 | 127,488 | 0.18% | 주식 |
| RAYMOND JAMES FINANCIAL INC | $408,047 | 119,312 | 0.17% | 주식 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $362,520 | 106,000 | 0.15% | 주식 |
| Allspring Global Investments Holdings, LLC | $356,879 | 99,687 | 0.15% | 주식 |
ETF 보유 현황 18 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| VFVA · VANGUARD WELLINGTON FUND | 0.17% | 426,785 SH | 2026년 8월 19일 | 일간 |
| QIDX · Spinnaker ETF Series | 0.11% | 14,310 NS | 2026년 7월 31일 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 62,833 SH | 2026년 8월 19일 | 일간 |
| IWC · iShares Trust | 0.02% | 248,081 SH | 2026년 9월 11일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 414,904 SH | 2026년 8월 19일 | 일간 |
| DFSV · Dimensional ETF Trust | 0.01% | 233,042 NS | 2026년 7월 31일 | N-PORT |
| RSSL · Global X Funds | 0.01% | 34,414 NS | 2026년 7월 31일 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.00% | 134,690 NS | 2026년 7월 31일 | N-PORT |
| IWM · iShares Trust | 0.00% | 1,902,936 SH | 2026년 9월 11일 | 일간 |
| PRF · Invesco Exchange-Traded Fund Trust | 0.00% | 96,796 SH | 2026년 10월 1일 | 일간 |
| DFAS · Dimensional ETF Trust | 0.00% | 29,296 NS | 2026년 7월 31일 | N-PORT |
| ITOT · iShares Trust | 0.00% | 105,616 SH | 2026년 9월 8일 | 일간 |
| IWV · iShares Trust | 0.00% | 19,827 SH | 2026년 9월 3일 | 일간 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 833,270 SH | 2026년 8월 19일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2,185,973 SH | 2026년 8월 19일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 6,453 SH | 2026년 8월 19일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.00% | 184,892 SH | 2026년 8월 19일 | 일간 |
| IWN · iShares Trust | · | 666,394 SH | 2026년 9월 11일 | 일간 |
ACH 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
12개월 목표 주가
4 명의 애널리스트 · 2026-09-30평균 목표 $1.51 +199.4%
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
회계연도 기준, 각 회사의 마지막 회계연도 말 종가 기준 가격입니다.
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요. 상단의 전체 기본 정보에서 원하는 행 옆의 +를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.